Pediatrix Medical Group, Inc. (NYSE:MD) Stock Position Raised by Smartleaf Asset Management LLC

Smartleaf Asset Management LLC lifted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 750.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,901 shares of the company’s stock after acquiring an additional 6,090 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Pediatrix Medical Group were worth $91,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Pacer Advisors Inc. acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter worth $35,492,000. Weiss Asset Management LP raised its holdings in shares of Pediatrix Medical Group by 50.5% during the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock worth $10,580,000 after acquiring an additional 306,143 shares in the last quarter. RBF Capital LLC purchased a new stake in shares of Pediatrix Medical Group during the third quarter worth $1,695,000. Rubric Capital Management LP raised its holdings in shares of Pediatrix Medical Group by 1.5% during the third quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock worth $95,907,000 after acquiring an additional 125,000 shares in the last quarter. Finally, Algert Global LLC purchased a new stake in shares of Pediatrix Medical Group during the third quarter worth $1,315,000. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Up 0.9 %

NYSE MD opened at $14.63 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The stock’s 50 day moving average is $14.08 and its two-hundred day moving average is $13.31. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of -12.19, a PEG ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on MD. UBS Group raised their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Truist Financial raised their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Mizuho raised their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Finally, Macquarie initiated coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.